Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Operating Leases (2020 - 2025)

Bio Essence (BIOE) has 6 years of Operating Leases data on record, last reported at $99668.0 in Q2 2025.

  • For Q2 2025, Operating Leases fell 92.85% year-over-year to $99668.0; the TTM value through Jun 2025 reached $99668.0, down 92.85%, while the annual FY2024 figure was $392290.0, 58.2% down from the prior year.
  • Operating Leases reached $99668.0 in Q2 2025 per BIOE's latest filing, down from $247164.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.4 million in Q1 2024 and bottomed at $99668.0 in Q2 2025.
  • Average Operating Leases over 5 years is $924758.4, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Operating Leases: surged 61.58% in 2024, then crashed 92.85% in 2025.
  • A 5-year view of Operating Leases shows it stood at $1.1 million in 2021, then decreased by 15.15% to $952756.0 in 2022, then fell by 1.51% to $938409.0 in 2023, then plummeted by 58.2% to $392290.0 in 2024, then crashed by 74.59% to $99668.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $99668.0 in Q2 2025, $247164.0 in Q1 2025, and $392290.0 in Q4 2024.